Affiliation: H. Lee Moffitt Cancer Center and Research Institute
- Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysisTawee Tanvetyanon
Head and Neck Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA
Am J Otolaryngol 30:38-43. 2009..Squamous cell carcinoma (SCC) is associated with IP in about 7% of cases. To date, there has been no pooled analysis to formulate a survival outcome associated with this rare condition...
- Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brandsTawee Tanvetyanon
Thoracic Oncology Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa FL 33612, USA
Cancer 113:150-7. 2008..In the current study, the authors investigated the risk of lung cancer associated with beta-carotene in smokers or former smokers and surveyed the beta-carotene content in national brand multivitamins...
- Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancerTawee Tanvetyanon
Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
J Clin Oncol 26:4610-6. 2008....
- Prognostic factors for survival after salvage reirradiation of head and neck cancerTawee Tanvetyanon
Head and Neck and ThoracicPrograms, and the Statistic Core, H Lee Moffitt Cancer Center andResearch Institute, Tampa, FL, USA
J Clin Oncol 27:1983-91. 2009..Reirradiation is a treatment option, although it is associated with substantial toxicities. We investigated potential prognostic factors, including comorbidity and pre-existing organ dysfunction, for survival after reirradiation...
- Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinomaTawee Tanvetyanon
Head and Neck Program, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
Arch Otolaryngol Head Neck Surg 135:687-92. 2009..To investigate the potential value of postoperative concurrent chemoradiation among patients with high-risk salivary gland carcinomas...
- Quality-of-care indicators for non-small cell lung cancerTawee Tanvetyanon
Department of Thoracic Oncology, the H Lee Moffitt Cancer Center, Tampa, Florida 33612, USA
Cancer Control 16:335-41. 2009..To date, the literature on quality-of-care indicators for non-small cell lung cancer (NSCLC) has not been reviewed...
- Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancersTawee Tanvetyanon
Department of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
J Thorac Oncol 5:1018-24. 2010..For those undergoing surgery, limited information exists on the relationship between tumor size and survival...
- A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancerTawee Tanvetyanon
H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA
J Thorac Oncol 2:1091-7. 2007..We evaluated available literatures to summarize the state of current knowledge and provide suggestions for future studies...
- Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancerGerold Bepler
Program and Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA
J Thorac Oncol 3:1112-8. 2008..The goal was to achieve a disease response rate of 50% and to determine if the expression levels of genes associated with GP metabolism are predictive of response...
- Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancerGerold Bepler
Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA
J Thorac Oncol 6:553-8. 2011..A reduction in both local and distant recurrence is needed to improve patients' outcome. Performing molecular studies on serially collected tumor specimens may result in a better selection of therapeutic options...
- Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancerEric B Haura
Department of Thoracic Oncology and Biostatistics, Clinical Trials and Clinical Pharmacology Core, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612 9497, USA
J Clin Oncol 28:1387-94. 2010....
- Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysisTawee Tanvetyanon
Biostatistics Division, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Dr, Tampa, FL 33613, USA
J Clin Oncol 26:1142-7. 2008..However, some suggest that the survival outcome among patients with a synchronous metastasis is poor. It remains unclear whether this treatment approach is warranted among those with synchronous metastasis...
- Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancerGeorge Simon
Program and Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612 9497, USA
J Clin Oncol 25:2741-6. 2007..We hypothesized that selection of double-agent chemotherapy based on tumoral RRM1 and ERCC1 expression would be feasible and beneficial for patients with advanced NSCLC...
- Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settingsVirendra Kumar
Department of Imaging, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612 9416, USA
Clin Nucl Med 38:175-82. 2013..In this study, we measured test-retest reproducibility of SUV measurements under clinical practice conditions and recorded recognized deviations from protocol compliance...
- Physician practice in the discontinuation of statins among patients with advanced lung cancerTawee Tanvetyanon
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
J Palliat Care 22:281-5. 2006..Lipid monitoring was suboptimal and, when it occurred, indicated the lipid goal was rarely achieved...
- Effects of self-directed stress management training and home-based exercise on stress management skills in cancer patients receiving chemotherapyKristin M Phillips
Division of Population Science, Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, MRC PSY, Tampa, FL 33612, USA
Stress Health 28:368-75. 2012..05). This study provides support for including an exercise component in SM interventions for cancer patients receiving chemotherapy (clinicaltrials.gov identifier: NCT00740038)...
- Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinomaTawee Tanvetyanon
Hematology and Oncology Section, Edward Hines, Jr. Veteran Administration Hospital, Hines, IL 60141, USA
Cancer 106:1554-9. 2006..However, the intensity of anemia management is low. A low baseline hemoglobin level and the reception of multiple concurrent chemotherapeutic agents are considered to be the main risk factors of anemia. Cancer 2006...
- Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumorsTawee Tanvetyanon
Cancer 103:1756-7; author reply 1757-8. 2005
- Acute lung injury associated with vinorelbineTawee Tanvetyanon
Division of Hematology/Oncology, and Lung Transplantation Program, Division of Pulmonary and Critical Care Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
J Clin Oncol 24:1952-3. 2006
- Octreotide for bleeding as a result of hepatocellular carcinoma invasion of the gastrointestinal tractTawee Tanvetyanon
J Gastroenterol Hepatol 18:231-2. 2003
- The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai versionThitiya Sirisinha
Medical Oncology Unit, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
J Med Assoc Thai 85:1210-9. 2002..The initial findings of the present study indicate that the Thai version of the EORTC QLQ-C30 is reliable. A validating process of this version is in progress with active patients accrual ongoing at present...
- Hypocalcemia and azotemia associated with zoledronic acid and interferon alfaTawee Tanvetyanon
Division of Hematology Oncology, Loyola University Stritch School of Medicine, Maywood, IL 60153 3304, USA
Ann Pharmacother 38:418-21. 2004..To describe severe hypocalcemia and acute renal failure associated with zoledronic acid and interferon alfa in a patient with metastatic carcinoid tumors...
- HER-2 and fluorescent in situ hybridization to evaluate breast cancerTawee Tanvetyanon
JAMA 292:328; author reply 328-9. 2004
- Mucoepidermoid carcinoma of the lung presenting as a cavitary lesionTawee Tanvetyanon
Department of Medicine, Loyola University Medical Center and Hines Veteran Affair Hospital, Maywood, IL, USA
J Med Assoc Thai 87:988-91. 2004..High-grade mucoepidermoid carcinoma of the lung may present as a cavitary lesion. The presence of M. tuberculosis should not preclude clinicians from pursuing adequate diagnostic procedures for a possible malignant lesion...
- Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapyTawee Tanvetyanon
Division of Hematology and Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois 60153, USA
Cancer 103:237-41. 2005..The practices of interest are the uses of dual-energy X-ray absorptiometry (DXA) scans, bisphosphonates, calcium or vitamin D supplement, calcitonin, or estrogen...
- Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancerTawee Tanvetyanon
J Natl Cancer Inst 97:70; author reply 70-1. 2005
- Neoadjuvant therapy: an emerging concept in oncologyTawee Tanvetyanon
Division of Hematology Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
South Med J 98:338-44. 2005..To date, the survival benefits of neoadjuvant therapy for resectable non-small cell lung, esophageal, gastric, and prostate cancer remains under investigation...
- Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?Tawee Tanvetyanon
Division of Hematology Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL 60153, USA
Anticancer Res 25:429-33. 2005..It seems possible that fludarabine, an immunosuppressive chemotherapy, accelerated the occurrence and progression of malignant mesothelioma during the therapy for his B-PLL...
- Molecular prediction of recurrence of breast cancerTawee Tanvetyanon
N Engl J Med 352:1605-7; author reply 1605-7. 2005
- Treatment of localized lymphomaTawee Tanvetyanon
N Engl J Med 352:2449-51; author reply 2449-51. 2005
- Consideration before administering cytotoxic chemotherapy to the critically illTawee Tanvetyanon
Crit Care Med 33:2689-91. 2005
- Concurrent administration of interferon alfa-2b and beta-1aTawee Tanvetyanon
Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA, USA
Ann Pharmacother 37:77-9. 2003..To describe the concurrent use of interferon (IFN) alfa and beta in a patient with multiple sclerosis (MS) and chronic myeloid leukemia (CML)...